Skip to main content

Table 2 The proportion of patients in CDAI/SDAI/DAS28 remission, low activity, moderate activity and high activity states at 0, 6 and 12 weeks. CDAI: Clinical Disease Activity Index; SDAI: Simplified Disease Activity Index; DAS28: Disease Activity Score in 28 joints (using ESR)

From: The rapid kinetics of optimal treatment with subcutaneous methotrexate in early inflammatory arthritis: an observational study

Remission score

Baseline No. (%)

6 weeks No. (%)

12 weeks No. (%)

Early (0–6 weeks) vs. Late (6–12 weeks) (p)

CDAI

N

102

96

89

 

Remission ( ≤ 2.8)

0 (0.0)

16 (16.7)

17 (19.1)

0.0002

Low Activity (2.9–10.0)

9 (8.8)

25 (26.0)

48 (53.9)

0.15

Moderate Activity (10.1–22.0)

26 (25.5)

37 (38.5)

21 (23.6)

 

High Activity ( > 22)

67 (65.7)

18 (18.8)

3 (3.4)

 

SDAI

N

97

58

37

 

Remission ( ≤ 3.3)

0 (0.0)

4 (6.9)

3 (8.1)

 

Low Activity (3.4–11.0)

3 (3.1)

13 (22.4)

16 (43.2)

0.08

Moderate Activity (11.1–26)

15 (15.5)

19 (32.8)

13 (35.1)

 

High Activity ( ≥ 26)

79 (81.4)

22 (37.9)

5 (13.5)

 

DAS28

N

94

85

76

 

Remission ( ≤ 2.4)

2 (2.1)

22 (25.9)

23 (30.3)

0.00002

Low Activity (2.5–3.6)

9 (9.6)

28 (32.9)

33 (43.4)

0.41

Moderate Activity (3.7–5.5)

40 (42.6)

29 (34.1)

19 (25.0)

 

High Activity ( ≥ 5.5)

43 (45.7)

6 (7.1)

1 (1.3)